1. Home
  2. ENOV vs VSCO Comparison

ENOV vs VSCO Comparison

Compare ENOV & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • VSCO
  • Stock Information
  • Founded
  • ENOV 1995
  • VSCO 1977
  • Country
  • ENOV United States
  • VSCO United States
  • Employees
  • ENOV N/A
  • VSCO N/A
  • Industry
  • ENOV Fluid Controls
  • VSCO Clothing/Shoe/Accessory Stores
  • Sector
  • ENOV Industrials
  • VSCO Consumer Discretionary
  • Exchange
  • ENOV Nasdaq
  • VSCO Nasdaq
  • Market Cap
  • ENOV 1.7B
  • VSCO 1.9B
  • IPO Year
  • ENOV 2008
  • VSCO N/A
  • Fundamental
  • Price
  • ENOV $33.02
  • VSCO $20.44
  • Analyst Decision
  • ENOV Strong Buy
  • VSCO Hold
  • Analyst Count
  • ENOV 5
  • VSCO 12
  • Target Price
  • ENOV $58.00
  • VSCO $26.50
  • AVG Volume (30 Days)
  • ENOV 1.6M
  • VSCO 3.6M
  • Earning Date
  • ENOV 08-06-2025
  • VSCO 08-27-2025
  • Dividend Yield
  • ENOV N/A
  • VSCO N/A
  • EPS Growth
  • ENOV N/A
  • VSCO 55.42
  • EPS
  • ENOV N/A
  • VSCO 2.07
  • Revenue
  • ENOV $2,150,191,000.00
  • VSCO $6,224,000,000.00
  • Revenue This Year
  • ENOV $8.23
  • VSCO $2.23
  • Revenue Next Year
  • ENOV $6.18
  • VSCO $1.77
  • P/E Ratio
  • ENOV N/A
  • VSCO $9.98
  • Revenue Growth
  • ENOV 18.32
  • VSCO 1.47
  • 52 Week Low
  • ENOV $28.83
  • VSCO $13.76
  • 52 Week High
  • ENOV $49.83
  • VSCO $48.73
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 53.33
  • VSCO 53.41
  • Support Level
  • ENOV $30.84
  • VSCO $18.40
  • Resistance Level
  • ENOV $33.82
  • VSCO $20.61
  • Average True Range (ATR)
  • ENOV 1.16
  • VSCO 0.94
  • MACD
  • ENOV 0.31
  • VSCO 0.19
  • Stochastic Oscillator
  • ENOV 81.84
  • VSCO 75.52

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About VSCO Victorias Secret & Co.

Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.

Share on Social Networks: